These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22998908)

  • 21. Metabolic study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to the enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in vitro in human bronchial epithelial cells using chiral capillary electrophoresis.
    Yang Y; Yu C; Zhou M; Pang N; Li N; Nie H; Liao J; Bai Y; Liu H
    J Chromatogr A; 2011 Sep; 1218(37):6505-10. PubMed ID: 21791338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined analysis of the tobacco metabolites cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine.
    Kotandeniya D; Carmella SG; Ming X; Murphy SE; Hecht SS
    Anal Chem; 2015 Feb; 87(3):1514-7. PubMed ID: 25544129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
    Hecht SS; Carmella SG; Ye M; Le KA; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 2002 Jan; 62(1):129-34. PubMed ID: 11782369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons.
    Anderson KE; Kliris J; Murphy L; Carmella SG; Han S; Link C; Bliss RL; Puumala S; Murphy SE; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1544-6. PubMed ID: 14693752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
    Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
    Brown PJ; Bedard LL; Reid KR; Petsikas D; Massey TE
    Drug Metab Dispos; 2007 Nov; 35(11):2086-94. PubMed ID: 17717079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
    Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' blood.
    Carmella SG; Han S; Villalta PW; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2669-72. PubMed ID: 16284395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone is correlated with 8-hydroxy-2'-deoxyguanosine in humans after exposure to environmental tobacco smoke.
    Chiang HC; Huang YK; Chen PF; Chang CC; Wang CJ; Lin P; Lee HL
    Sci Total Environ; 2012 Jan; 414():134-9. PubMed ID: 22138374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine.
    Carmella SG; Ye M; Upadhyaya P; Hecht SS
    Cancer Res; 1999 Aug; 59(15):3602-5. PubMed ID: 10446969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.
    Park SL; Carmella SG; Ming X; Vielguth E; Stram DO; Le Marchand L; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):561-9. PubMed ID: 25542827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Zimmerman CL; Wu Z; Upadhyaya P; Hecht SS
    Carcinogenesis; 2004 Jul; 25(7):1237-42. PubMed ID: 14988218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users.
    Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple high-throughput analytical method using ultra-performance liquid chromatography coupled with tandem mass spectrometry to quantify total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine.
    Yang JY; Ahn HK; Lee SW; Han YJ; Oh YJ; Velázquez-Armenta EY; Nava-Ocampo AA
    Clin Chem Lab Med; 2015 Jul; 53(8):1249-57. PubMed ID: 25720081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
    Murphy SE; Carmella SG; Idris AM; Hoffmann D
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
    Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine.
    Byrd GD; Ogden MW
    J Mass Spectrom; 2003 Jan; 38(1):98-107. PubMed ID: 12526011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
    Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
    Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
    Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.
    Breyer-Pfaff U; Martin HJ; Ernst M; Maser E
    Drug Metab Dispos; 2004 Sep; 32(9):915-22. PubMed ID: 15319331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.